Clinical Proof of Concept Studies in Cancer Drug Development

White Paper – Clinical Research Services Turku CRST
Clinical Proof of Concept Studies in Cancer Drug Development

CRST Logo

Contact Supplier: Clinical Research Services Turku CRST
Supplier White Paper: Clinical Proof of Concept Studies in Cancer Drug Development
Address: University of Turku – CRST, FI – 20014 University of Turku, Finland
Tel: +358 2333 7502, +358 2333 7635
Fax: +358 2251 0046
Website: www.crst.fi

Clinical Proof of Concept Studies in Cancer Drug Development


CRST offers efficient and comprehensive services for proof-of-concept studies.

The link below is for the full presentation of CRST’s and Turku PET Centre’s imaging services for proof-of-concept in cancer drug development.

Please click on the following link for the full article.
Clinical Proof of Concept Studies in Cancer Drug Development


Comments are closed.